Inhibitory effect of sildenafil on the human isolated seminal vesicle

BJU International

Volumn 100, Issue 6, 2007, Pages 1322-1325

  Gajar, Sessin A ^a   Tano, Tania ^a   Resende, Ângela C ^a   Bitencourt, José Augusto F ^a   De Lemos Neto, Miguel ^a   Damião, Ronaldo ^a   Criddle, David N ^b   Soares De Moura, Roberto ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Human seminal vesicle; KCl; Noradrenaline; Sildenafil

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; NORADRENALIN; PHOSPHODIESTERASE V; POTASSIUM CHLORIDE; SILDENAFIL;

ADULT; AGED; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; ISOLATION PROCEDURE; MALE; MUSCLE RELAXATION; PREMATURE EJACULATION; PRIORITY JOURNAL; SEMINAL VESICLE; SUSPENSION;

AGED; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NOREPINEPHRINE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; POTASSIUM CHLORIDE; PURINES; SEMINAL VESICLES; SULFONES;

EID: 35748972610     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07260.x     Document Type: Article

References (24)

1. Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practionary. J Public Health Med 1977 19 : 387 91
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. prevalence and predictors. JAMA 1999 281 : 537 44
3. Azam U. Late-stage clinical development in lower urogenital targets: sexual dysfunction. Br J Pharmacol 2006 147 : S153 9
4. Heuer O, Uckert S, Machtens SA et al. Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro. Urology 2002 59 : 958 62
5. Machtens S, Ückert S, Stief CG, Tsikas D, Frölich JC, Jonas U. Effects of various nitric oxide-donating drugs on adrenergic tension of human seminal vesicles in vitro. Urology 2003 61 : 479 83
6. Boolell M, Allen MJ, Ballard SA et al. Sidenafil: an oral active type 5 cycle GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996 8 : 47 52
7. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998 159 : 2164 71
8. Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001 13 : 41 5
9. Orhan I, Onur R, Tasdemir C, Ayar A, Kadioglu A. Sildenafil citrate inhibits agonist induced contractions in isolated rat seminal vesicles. J Urol 2006 175 : 2350 3
10. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-smooth muscle myosin II. J Physiol 2000 522 : 177 85
11. Simonsen U, Garcia-Sacristan A, Prieto D. Penile arteries and erection. J Vasc Res 2002 39 : 283 303
12. Ückert S, Stanarius A, Stief CG, Wolf G, Jonas U, Machtens S. Immunocytochemical distribution of nitric oxide synthase in the human seminal vesicle: a light and electron microscopical study. Urol Res 2003 31 : 262 6
13. Grozdanovic Z, Goessl C. Comparative localization of heme oxygenase-2 and nitric oxide synthase in the autonomic innervation of the human ductus deferens and seminal vesicle. J Urol 1999 162 : 2156 61
14. Ehren I, Adolfsson J, Wiklund NP. Nitric oxide synthase activity in the human urogenital tract. Urol Res 1994 22 : 287 90
15. Py J, Dixon JS, Gosling JA. Co-localization of nitric oxide synthase, neuropeptides and tyrosine hydroxylase in nerves supplying the human post-natal vas deferens and seminal vesicle. Br J Urol 1997 80 : 291 9
16. Wayman C, Phillips S, Lunny C et al. Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology. Int J Impot Res 2005 17 : 216 23
17. Weeks JL, Zoraghi R, Beasley A, Sekhar KR, Francis SH, Corbin JD. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients. Int J Impot Res 2005 17 : 5 9
18. Lau LC, Adaikan PG. Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum. Eur J Pharmacol 2006 541 : 184 90
19. Nicholson CD, Challiss SA, Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 1991 12 : 19 27
20. Salonia A, Maga T, Colombo R et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002 168 : 2486 9
21. Su YH, Chen SH, Zhou H, Vacquier VD. Tandem mass spectrometry identifies proteins phosphorylated by cyclic AMP-dependent protein kinase when sea urchin sperm undergo the acrosome reaction. Dev Biol 2005 285 : 116 25
22. Lefievre L, De Lamirande E, Gagnon C. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction. J Androl 2000 21 : 929 37
23. Baxendale RW, Fraser LR. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation. Mol Reprod Dev 2005 71 : 495 508
24. Kriegsfeld LJ, Demas GE, Huang PL, Burnett AL, Nelson RJ. Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-). Physiol Behav 1999 67 : 561 6